AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ETRAVIRINE

12 registrations across 7 African markets— 9 active

Markets with ETRAVIRINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Intelence
Tablet Uncoated
🇿🇲ZambiaJANSSEN – CILAG INTERNATIONAL NVactiveJul 2030
Intelence 100 mg Tablet**
Tablet
🇳🇬NigeriaBlooms Pharm LtdactiveJun 2030
INTELENCE 100MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
INTELENCE 100MG COMPRIME BOITE DE 120🇨🇮Côte d'IvoireJANSSEN CILAG INTERNATION NVexpiredDec 2020
INTELENCE 100MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2015
Etravirine Tablet 25mg
Tablet
🌍WWJanssen-Cilag International NVactive
INTELENCE
comprimé / 25mg
🇸🇳SenegalASPEN PHARMACAREactive
Etravirine Tablet 100mg
Tablet
🌍WWJanssen Research & Development LLCactive
ETRAVIRINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaJANSSEN-CILAG INTERNATIONAL NVactive
ETRAVIRINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaJANSSEN-CILAG INTERNATIONAL NVactive
ETRAVIRINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaJANSSEN-CILAG INTERNATIONAL NVactive
ETRAVIRINE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaJANSSEN-CILAG INTERNATIONAL NVactive

ETRAVIRINE in Africa — Regulatory Overview

ETRAVIRINE is registered across 7 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, WW, Malawi, Zambia and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 9 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.